Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of February 2026, with a report date of February 17, 2026. The document serves as a transaction notification regarding insider trading activities by a Person Discharging Managerial Responsibilities (PDMR).
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details a specific equity transaction:
- Instrument: American Depositary Shares (ADS), ISIN: US37733W2044.
- Transaction Type 1 (Vesting): Vesting of 10,836.957 ADS at a price of $0.00.
- Transaction Type 2 (Sale): Sale of 4,009.778 ADS at a price of $58.8509 per share.
- Exchange: New York Stock Exchange (XNYS).
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document records a routine equity event involving the vesting of performance share awards granted in 2020 under the 2017 Performance Share Plan, which included a voluntary 3-year deferral.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. The sale of shares was executed specifically to meet tax liabilities associated with the vesting of the awards.
Investor Verification Points
- Verify the identity of the PDMR: Maya Martinez-Davis, President, US.
- Confirm the transaction date: February 13, 2026.
- Note that the sale volume (4,009.778 ADS) represents a portion of the total vested volume (10,836.957 ADS).
- Recognize that this filing does not contain quarterly or annual financial performance data.